NWG — Autoantibodies, Glutamic Acid Decarboxylase (Gad) Class II

FDA Device Classification

FDA product code NWG covers "Autoantibodies, Glutamic Acid Decarboxylase (Gad)", a Class II medical device regulated under 21 CFR 866.5660. Submissions are reviewed by the Immunology panel. At least 2 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
NWG
Device Class
Class II
Regulation Number
866.5660
Submission Type
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Definition

The device is used for the semi-quantitative determination of glutamic acid decarboxylase (GAD) autoantibodies in human serum as an aid in the diagnosis of Type I diabetes mellitus (autoimmune mediated diabetes).

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K072135kronus market development associatesKRONUS GAD AUTOANTIBODY ELISA ASSAY KITNovember 7, 2007
K051061kronus market development associatesKRONUS GLUTAMIC ACID DECARBOXYLASE ANTIBODY KITNovember 4, 2005